<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(1)</volume><submitter>Xiu M</submitter><funding>Zhongshan Hospital Special Fund for Specialist Physicians</funding><funding>Specialty Feature Construction Project of Shanghai Pudong New Area Health Commission</funding><funding>Beijing Xisike Clinical Oncolgoy Research Foundation</funding><funding>National Natural Science Foundation of China</funding><funding>Shanghai Sailing Program</funding><journal>Discover oncology</journal><pagination>238</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12872989</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>LRRC31 is a novel prognostic biomarker and therapeutic target for colorectal cancer.</pubmed_title><pmcid>PMC12872989</pmcid><funding_grant_id>Y-HH202102-0001</funding_grant_id><funding_grant_id>82160468</funding_grant_id><funding_grant_id>PWZzb2022-08</funding_grant_id><funding_grant_id>ZP2022-001</funding_grant_id><funding_grant_id>23YF1438600</funding_grant_id><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Xiu M</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Yu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>LRRC31 is a novel prognostic biomarker and therapeutic target for colorectal cancer.</name><description/><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-05T03:18:01.454Z</modification><creation>2026-07-05T03:11:32.803Z</creation></dates><accession>S-EPMC12872989</accession><cross_references><pubmed>41495324</pubmed><doi>10.1007/s12672-026-04382-w</doi></cross_references></HashMap>